In a breakthrough study published in the journal Nature Catalysis, an international research team has developed a new catalyst that can electronically control the functionalization of chiral molecules. This novel catalyst, based on an iron-based compound, has the potential to revolutionize the production of enantiomerically pure chiral molecules, which are essential components in the production of pharmaceuticals. The research team, led by Professor Kazuhiro Takanabe at the University of Tokyo, was able to fine-tune the structure of the catalyst to facilitate the efficient functionalization of chiral molecules. This new catalyst could potentially reduce the cost of producing enantiomerically pure chiral molecules, making them more accessible to pharmaceutical companies.

Read Full Article Here

source: Phys.org